BOBS
Bob's Discount Furniture, Inc.
BOBS has the edge over NIO overall, supported by stronger modeled upside.
NIO
NIO Inc.
NIO has lower modeled downside risk, despite its lower overall score.
BOBS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
BOBS's revenue, profitability, cash flow and balance sheet are all currently healthy.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
BOBS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $15.74 | -24% |
| Fair | 17x | $18.59 | -9.9% |
| Expensive | 19x | $20.33 | -1.5% |
| Current | 19x | $20.64 | — |
Historical ranges are pointers, not guarantees.
BOBS's PE is 19x, but its earnings don't support one, so it isn't a reliable read right now.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
BOBS Forward outlook
There aren't enough analyst estimates for BOBS to show an outlook.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
BOBS Earnings Per Share
BOBS and NIO do not have enough comparable growth data to identify a winner.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
BOBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $680.4M | +10% |
| Q2 2026 | $619.6M | +8.8% |
| Q1 2026 | $578.1M | +8.5% |
| Q4 2025 | $648.8M | +8.2% |
BOBS's revenue has grown year over year every quarter since late 2025: $680M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.7% | +0.3 points |
| Q2 2026 | 13% | +4 points |
| Q1 2026 | 3% | -0.9 points |
| Q4 2025 | 9.2% | N/A |
| Q3 2025 | 8.3% | -1 points |
| Q2 2025 | 8.7% | N/A |
| Q1 2025 | 3.9% | N/A |
| Q4 2024 | 9.3% | N/A |
BOBS has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over BOBS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
BOBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $81.3M | +30% |
| Q2 2026 | $36M | +248% |
| Q1 2026 | -$2.7M | +$9.4M |
| Q4 2025 | $20.7M | -60% |
BOBS has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
BOBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +586K shares |
| 1 year | +4.5% | +5.9M shares |
BOBS has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $50,000 |
| Q4 2025 | $17,000 |
| Q3 2025 | $401,000 |
| Q2 2025 | $626,000 |
| Q1 2025 | $83,000 |
| Q4 2024 | $358,000 |
BOBS has spent almost nothing on buybacks in the past year.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
BOBS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 1.4x | Healthy |
BOBS has more cash than debt.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BOBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.2 | Overbought |
| Stochastic | 78.2 | Neutral |
BOBS's weekly RSI is 71 (overbought) and its Stochastic is 78 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
BOBS PE vs Consumer Cyclical Sector
| Metric | BOBS | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 6% above |
| PE % | 95 | 13 | 82 pts above |
BOBS is trading at 19x earnings, in line with the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
BOBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.2 | 27% above |
| 20 week MA | $16.5 | 25% above |
BOBS has stronger trend alignment. BOBS is above 2 of 2 weekly averages versus NIO above 0 of 5.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
BOBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $16.5 | $20.6 | +25% |
BOBS has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.